S. Polyakov
Impact in
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism
Papers in
-
- Prostate Cancer Treatment and Research 6
- Gastric Cancer Management and Outcomes 1
- Oncology 4
- Cancer-related Molecular Pathways 2
- CAR-T cell therapy research 1
- Cancer Treatment and Pharmacology 1
- Co-authors
- Egils Vjaters (5 shared papers)Toni Sarapohja (5 shared papers)Karim S. Fizazi (5 shared papers)B. Yа. Alekseev (5 shared papers)Neal D. Shore (5 shared papers)Mindaugas Jievaltas (5 shared papers)Albertas Ulys (5 shared papers)Murilo de Almeida Luz (5 shared papers)
- Journals
- Annals of Oncology (3 papers)New England Journal of Medicine (2 papers)World Journal of Urology (1 paper)International Journal of Gynecological Cancer (1 paper)JAMA Oncology (1 paper)
- Partner nations
- BelarusUnited StatesRussia
In The Last Decade
S. Polyakov
15 papers receiving 1.1k citations
S. Polyakov's Hit Papers
Peers
Comparison fields: 5 of 59
- Pulmonary and Respiratory Medicine 888
- Cancer Research 196
- Oncology 196
- Radiology, Nuclear Medicine and Imaging 156
- Endocrinology, Diabetes and Metabolism 104
Countries citing papers authored by S. Polyakov
This map shows the geographic impact of S. Polyakov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Polyakov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Polyakov more than expected).
Fields of papers citing papers by S. Polyakov
This network shows the impact of papers produced by S. Polyakov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Polyakov. The network helps show where S. Polyakov may publish in the future.
Co-authors
The 25 scholars most cited alongside S. Polyakov, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer Hit paper breakdown → | 2019 | 697 |
| 2 | Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide Hit paper breakdown → | 2020 | 277 |
| 3 | 2022 | 74 | |
| 4 | 2016 | 33 | |
| 5 | 2021 | 28 | |
| 6 | 2016 | 18 | |
| 7 | 2022 | 9 | |
| 8 | 2020 | 9 | |
| 9 | 2019 | 3 | |
| 10 | 2024 | 3 | |
| 11 | 2017 | 2 | |
| 12 | 2021 | 2 | |
| 13 | 2021 | 2 | |
| 14 | 2020 | 2 | |
| 15 | 2021 | 1 | |
| 16 | 2024 | 0 | |
| 17 | 2019 | 0 | |
| 18 | 2026 | 0 | |
| 19 | 2025 | 0 |
About S. Polyakov
S. Polyakov is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Biotechnology, Surgery and Obstetrics and Gynecology, having authored 19 papers that have together received 1.2k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (6 papers), Bladder and Urothelial Cancer Treatments (4 papers), Cancer Research and Treatments (2 papers), Cancer-related Molecular Pathways (2 papers), Multiple and Secondary Primary Cancers (1 paper), Gastric Cancer Management and Outcomes (1 paper), CAR-T cell therapy research (1 paper) and Cancer Treatment and Pharmacology (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (888 citations), Cancer Research (196 citations), Oncology (196 citations), Radiology, Nuclear Medicine and Imaging (156 citations) and Endocrinology, Diabetes and Metabolism (104 citations). S. Polyakov has collaborated with scholars based in Belarus, United States and Russia. Frequent co-authors include Egils Vjaters, Toni Sarapohja, Karim S. Fizazi, B. Yа. Alekseev, Neal D. Shore, Mindaugas Jievaltas, Albertas Ulys, Murilo de Almeida Luz, Teuvo L.J. Tammela and Amir Snapir. Their work appears in journals such as Annals of Oncology, New England Journal of Medicine, World Journal of Urology, International Journal of Gynecological Cancer and JAMA Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.